Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T20:32:47.690Z.
Calculation as of: 2026-10-06T20:32:47.690Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4fd5d7af3ee6af72921bc315e5ba82b5757c441ca2a41ed9c1ba6c6f3afb8810
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Regencell Bioscience Holdings Limited
Market Cap
$3.64B
PS Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.54B
PS Ratio
N/A
TTM Avg
436.18
3Y Avg
3953.03
5Y Avg
1750.10
Market Cap
$3.44B
PS Ratio
2905.64
TTM Avg
5949.66
3Y Avg
5949.66
5Y Avg
2255.37
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Regencell Bioscience Holdings Limited (RGC) | $3.64B | N/A | N/A | N/A | N/A |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.57B | 66.26 | 43.40 | 26.92 | 23.78 |
| Veracyte, Inc. (VCYT)vs › | $3.56B | 6.34 | 6.52 | 5.84 | 6.67 |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.54B | N/A | 436.18 | 3953.03 | 1750.10 |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | 4.27 | 6.09 | 6.09 | 7.49 |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | 14.88 | 44.87 | 169.56 | 109.21 |
| Celcuity Inc. (CELC)vs › | $3.47B | N/A | N/A | N/A | N/A |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | 2905.64 | 5949.66 | 5949.66 | 2255.37 |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 2.97 | 3.85 | 3.95 | 5.00 |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | N/A | N/A | N/A | N/A |
Half-year reporter: no trailing two-half-year basis, because the newest half-year ended more than 270 days before this quote.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
